## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.7% below STRENGTH zone (4.0-10.0%); PEG 3.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($564.76)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Retired Navy Adm. Michael Gilday, Former Northrop CFO David Keffer Join CACI Board**
- Source: ExecutiveBiz | 20260102T160858 | Somewhat-Bullish | Relevance: 73%
- CACI International has appointed retired Navy Adm. Michael Gilday and former Northrop Grumman CFO David Keffer as independent directors to its board. Lisa Disbrow, chair of CACI's board, highlighted their extensive leadership and defense sector knowledge as assets that will strengthen CACI's ability to deliver solutions and drive shareholder value. Gilday is a former Chief of Naval Operations, and Keffer brings significant financial leadership experience from Northrop Grumman and other GovCon entities.

**2. S&P Global Inc. $SPGI Shares Sold by Calamos Advisors LLC**
- Source: MarketBeat | 20251231T095820 | Somewhat-Bullish | Relevance: 68%
- Calamos Advisors LLC reduced its stake in S&P Global Inc. by 11.9% in the third quarter, while several other institutional investors significantly increased their positions. Despite Calamos's sale, the consensus Wall Street rating for S&P Global remains "Buy" with an average price target of $614.93, suggesting potential upside from its current share price. The article also provides a financial overview of S&P Global, highlighting its market capitalization, P/E ratio, and recent earnings data.

**3. RTX stock today: Pratt & Whitney settlement in focus as Wall Street shuts for New Yearâ€™s Day**
- Source: ts2.tech | 20260102T000928 | Neutral | Relevance: 64%
- RTX's Pratt & Whitney Canada unit has settled an antitrust lawsuit concerning used aircraft engine sales, a key development for investors closely watching the "aftermarket" business. Although settlement terms are undisclosed, investors are scrutinizing potential one-time charges or operational changes. The stock closed down 0.33% on December 31, and attention now turns to upcoming U.S. economic data and RTX's late-January earnings report.

**4. EagleNXT Announces Successful Drone and Sensor Sale to U.S. Army**
- Source: GlobeNewswire | 20260102T130216 | Somewhat-Bullish | Relevance: 64%
- EagleNXT has successfully sold six eBee TAC tactical mapping drones to the U.S. Army, equipped with advanced S.O.D.A. 3D and Duet M sensors. This sale, facilitated through Dronivo GmbH, addresses the growing demand for rapid and reliable aerial data collection for tactical mapping and intelligence gathering in dynamic environments. The eBee TAC drones offer centimeter-level accuracy and are designed for various defense missions, including border surveillance, operational planning, and search and rescue.

**5. The Truth About Textron Inc: Why Wall Street Is Quietly Hoarding TXT**
- Source: AD HOC NEWS | 20251231T013352 | Neutral | Relevance: 64%
- Textron Inc. (TXT) is a diversified industrial conglomerate quietly selling drones, defense systems, and private jets, attracting "smart money" rather than viral social media hype. While not a meme stock, its strong business in defense spending, aviation, and luxury travel, along with steady long-term stock performance, positions it as a solid, "workhorse" investment for a conservative portfolio. The article suggests TXT is a "quiet cop" for investors seeking durable businesses over quick speculative gains.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Morgan Stanley | $714 | $720 | -1% |
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Morgan Stanley | main | Overweight |
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +2.2% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.76 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $83.9B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.76 |
| Forward P/E | 20.3 |
| Current P/E | 22.5 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.5% to 3.7% (+2.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.3pp (needs >4.0% for momentum thesis). MRS_5 at 2.2% confirms short-term momentum alignment. AM_20 at 3.1% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.78), confirming momentum. RSI neutral at 59. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.68% (CS: 84) | Neutral |
| RSI_14 | 59.4 | Neutral |
| MACD Histogram | 1.78 | Bullish |
| vs SMA20 | 1.031x | Above |
| vs SMA50 | 1.027x | Above |
| vs SMA200 | 1.074x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $585.66
- **Stop Loss:** $564.76 (3.6% risk)
- **Target:** $606.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 68
- **Position Value:** $39,824.88
- **Portfolio %:** 39.82%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*